Exagen Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Exagen stock has a consensus rating of "Strong Buy" and an average price target of $8.67. The average 1-year stock price forecast is 102.10% higher than the current stock price, while the lowest is $8.00 (+86.48%) and the highest is $10 (+133.10%).

Price Target: $8.67 (+102.10%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.67	$8.00	$10
Change	+86.48%	+102.10%	+86.48%	+133.10%

Analyst Ratings

The average analyst rating for Exagen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	8	7	7	7
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Brackmann William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	May 12, 2026
Kyle Mikson CFA Canaccord Genuity	Canaccord Genuity	Buy Maintains $8	Buy	Maintains	$8	+86.48%	May 12, 2026
Mark Massaro BTIG	BTIG	Buy Reiterates $9 → $8	Buy	Reiterates	$9 → $8	+86.48%	May 12, 2026
Daniel Brennan TD Cowen	TD Cowen	Buy Maintains $10 → $8	Buy	Maintains	$10 → $8	+86.48%	May 11, 2026
Anderson Schock B. Riley Securities	B. Riley Securities	Buy Maintains $8	Buy	Maintains	$8	+86.48%	Mar 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

71.58M

from 66.58M

7.52%

from 66.58M

Revenue Next Year

79.37M

from 71.58M

10.88%

from 71.58M

EPS This Year

-0.65

from -0.84

EPS Next Year

-0.43

from -0.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	48.30M	45.56M	52.55M	55.64M	66.58M	71.58M
Revenue Growth	15.07%	-5.67%	15.33%	5.89%	19.65%	7.52%
Gross Profit	27.71M	21.35M	29.46M	33.11M	38.80M	42.21M
Gross Margin	57.37%	46.86%	56.06%	59.51%	58.28%	58.96%
Operating Income	-24.07M	-40.15M	-22.84M	-13.64M	-14.07M	-12.65M
Net Income	-26.85M	-47.39M	-23.69M	-15.12M	-19.95M	-16.59M
EPS	-	-	-	-	-0.84	-0.65
Free Cash Flow	-13.05M	-22.48M	-9.27M	-8.25M	-10.36M	-14.15M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	72.0M
Avg	71.6M
Low	71.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.1%
Avg	7.5%
Low	6.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.65
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-